Clinical Trial Update: A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase III multinational, investigator-masked, active-controlled trial comparing DE-130A with Xalatan (latanoprost) in open-angle glaucoma or ocular hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Ocular Surface Disease
• Open-angle Glaucoma

Drugs mentioned

• DE-130A
• Xalatan (latanoprost)

Snippet

Sponsor: Santen SAS | Conditions: Open-Angle Glaucoma or Ocular Hypertension, Ocular Surface Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-05-28